Introduction
The absence of vitamin K induces the generation of new proteins (decarboxyproteins) in human and bovine blood (l) instead of the clotting factors II, VII, IX, and X. These decarboxyproteins are immunologically identical to their respective corresponding clotting factors but lack their functional activity.
After their discovery in 1963 (4) it lasted about 10 years before Fernlund et al. (3) elucidated the difference between decarboxyproteins and the normal clotting factors. It appeared that prothrombin (factor II) is decarboxyprothrombin with 10 of its glutamic acid residues (Glu) converted into 7-carboxyglutamic acid residues (Gla). The Gla residues give prothrombin its ability to bind Ca2* and to act as the normal zymogen of thrombin.
Up to now, several authors showed that liver microsomes from vitamin Kdeficient rats mediate in the incorporation of l4C-labelled CO2 into a protein, which is supposed to be an endogenous precursor of prothrombin and which accumulates in the rat liver during vitamin K deficiency (l) . Hence the ratliver cell-free system contains both, the enzyme and the substrate. Obviously this hampers further purification of the enzyme system.
Here we present evidence that separately purified decarboxyfactor II obtained from coumarin-treated cows, can be converted into prothrombin by a partly purified fraction from the microsomes of normal cow liver. The decarboxyfactor II converting enzyme system was called factor II synthetase, and was defined as the activity that is able to decrease the one-stage clotting time (factor II assay) of the reaction mixture during incubation at 37 'C. As will be published elsewhere, this decrease of the clotting time is due to the conversion of the added decarboxyfactor II into factor II.
The Synthesis of Prothrombin from lts Precursor Protein
Results and Discussion
Partial Purification of Foctor II Synthetase Crude llver microsomes were prepared as described previously (7) and supplemented with Triton X-100 to a final concentration of 2%. After centrifugation for I h at 150,0009 the supernatant was applied to a Sepharose 4-B column. Two activity peaks were eluted from the column (fig. lA) . The activity present at the position of high molecular weight material was pooled, concentrated and applied for a second time to the same column. It appeared that most of the activity had dissociated into the low molecular weight form ( fig. I B) . The latter fractions were pooled, concentrated and used as semipurified factor II synthetase.
Reaction Conditions Required for Factor II Synthesis As already described (7), the synthesis of factor II depends on the temperature, the pH and the ionic conditions. Optima were found at 3'7 "C ,50 mM KCl, IOmM tris-HCl and pH 7.8*8.5. When we investigated the dependence of the reaction on cofactors such as vitamin K1 or HCO3 it appeared necessary to work with limiting amounts of factor II synthetase. The best results were obtained when the reaction velocity was about 3O% of its maximal value. When high amounts of factor II synthetase were added to the incubation mixture, the reaction was hardly dependent on any cofactor. This can be explained by the fact that the factor Il-synthesizingenzyme is prepared from normal healthy cow livers in which factor II synthesis is at its height. It seems probable that in an enzyme system of this type all kinds of intermediates are present in which vitamin K and/or HCO3 are already fixed somewhere in the efizyme that has just been stopped from synthesizing factor II by our isolation procedure and not (like in the rat system) by vitamin K deficiency of the intact animals.
High amounts of synthetase would include sufficient cofactors for a normal reaction velocity. After about t h the reaction is then not inhibited by a shortage of some cofactor but by the reaction product (see below). In this way we found that the reaction components that are absolutely required for factor II synthesis are: decarboxyfactor II and semipurified factor II synthetase. The amount of factor II synthesized in 1|, h was hardly stimulated by adding vitamin K1 (see table I ). However, when the vitamin K antagonist warfarin (5 nX,I) was added instead of vitamin K1 , the synthesis of factor II was blocked. Only a residual synthetase activity occurred in the first 10min and the system could be partially reactivated by adding vitamin K1 . This means that vitamin K is probably present in our partly purified enzyme preparation and that its presence is important for the function of factor II synthetase.
Furthermore, the reaction also needs molecular oxygen. The amount of oxygen, that is normally dissolved in our buffers, is enough to give a normal Vermeer lHemker /Soute Fig. 1 . The partial purification of factorll synthetase. / Crude microsomes were solubilized and centrifuged (see text) and 5 ml of the supernatant were applied to a Sepharose 4-B column (2t12 x 100 cm) in buffer A (50 mM KCl, 10 mM Tris-HCl, pH 7.8).
Fractions of 90 drops were collected, and assayed by adding 50 pl of each fraction to 50 pl of a mixture containing 2 mM NaHCO 3, 0.2 mM vitamin K, and 0.8 U/ml of purified decarboxyfactor II (8) in buffer A. These mixtures were incubated at 37 'C for 1t/, h and subsequently diluted 4 times with cold buffer A. The diluted mixtures were assayed in the one-stage factor II assay (6) and the difference in the clotting time between incubated and nonincubated mixtures was used to measure the amount of factor II synthesized during the reaction. The clotting time of nonincubated mixtures (about 200 sec) is brought about by the prothrombin actMty of decarboxyfactor II (8). After incubation the clotting times of active fractions were about 50 sec. -B The first peak, containing high molecular weight material was applied h second time on the same column. The synthetase activity appeared to be partidlly dissociated into the low molecular weight form. Fractions containing the low molecular weight synthetase activity were pooled and used as semipurified factor II synthetase. The purification was about 10,000-fold. reaction velocity so the only way to demonstrate the oxygen dependency of the reaction is to introduce an oxygen-consuming enzyme system (like glucose/ glucose oxydase) in our buffers and protein solutions and to remove all dissolved oxygen prior to prothrombin synthesis. When a critical amount of glucose is added, the reaction becomes absolutely dependent on the presence of oxygen in the gasphase (table l) . Finally, we investigated the role of bicarbonate ions in the synthesis of factor II. As the only difference between decarboxyfactor II and factor II is the presence of l0 extra carboxyl groups in factor II, a carboxylation of our decarboxyfactor II should take place, although we did not observe any dependency of the reaction on added NaHCO3 (table I ). Yet the rat system is able to use HCO3 for its carboxylation of prothrombin precursor (2). We realized that like oxygen, also C02 might be dissolved in our buffers to a sufficient extent for a normal reaction velocity. Therefore, we added toc-labelled NaHCO3 to reaction mixtures which werc analyzed on Sephadex G-100 columns after the reaction had been completed. In this way we observed that the increase of factor II activity occurs in parallel with the incorporation of r4CO, into protein ( fig. 2) . Both, the newly formed factor II activity and the toc label were eluted at the same position as nonconverted decarboxyfactor II, namely with a maxi mum at fraction 15. This demonstrates that the molecular weight of the reaction product is similar to that of decarboxyfactor II and factor II and strongly suggests that also in the bovine system the incorporation ofcarboxyl groups into decarboxyfactor II transforms the latter into factor II.
Other cofactors, such as ATP, NADH or dithiothreitol (DTT) did not stimulate the synthesis of factor II. This is in contrast to earlier experiments (7) Vermeer/Hemker/Soute 2,OOO Fig.2 . Fractionation of reaction mixtures after factor II synthesis. Three reaction mixtures (1 ml) containing either decarboxyfactor II (0.4 U/ml, experiment a), or synthetase (0.01 ODrro units, experiment b) or a combination thereof (experiment c) were incubated at the conditions described in the legend to figure 1, except that unlabelled HCO; was replaced by 50 g.Ci NaHroCO, (60 mCi/mmol). After incubation the reaction mixtures were dialyzed against buffer A for 2 h with two changes of the buffer. Subsequently they were applied to a Sephadex G-100 column (1 X 40 cm) in buffer A. Fractions of 20 drops were collected and analyzed for the presence of decarboxyfactor II (Echis Carinatus assay, see ref. 6), factor II (one-stage coagulation assay) and '"C-label. * = Decarboxyfactor II (experiments a and c); * = factor II (experiment a); * = factor II (experiment c);o = dpm/ml (experiment a); o = dpm/ml (experiment c). The fraction of experiment b did not contain any radioactivity.
in which we used crude microsomes instead of the semipurified enzyme. Similar observations were reported by Esmon and Suttie (2) , who found ATP-dependent factor II synthesis in crude microsomes but ATP-independent factor II synthesis in the soluble system. However, on other points such as the dependencyof the reaction on NADH and reducing agents (DTT) our bovine system differs from that of Esmon and Suttie (2) and is more similar to that described by Lowenthd and Jaeger (5).
Feedback Inhibition of hothrombin Synthesis
As is shown in figure 3A , a time curve of prothrombin synthesis is straight during the first minutes, but then it gradually flattens and after about 5% of all decarboxyfactor II is consumed, no further conversion of decarboxyfactor II
The Synthesis of Prothrombin from Its Precursor Protein TIME, min Frg 3. Time murse of prothrombin synthesis..4 The generation of factor II activity in normal reaction mixtures (see the legend to figure 1, e) and in reaction mixtures to which 0.1 U/ml of factor II is added 30 min (*) or 85 min (*) after the start of the reaction. .B The incorporation of taCO, into BaSOo-adsorbable proteins. Normal reaction mixtures as described in the legend to figure 2 (o), reaction mixtures containing 0.1 U/ml of factor II (*), or mixtures in which vitamin K, is replaced by 5 mM of warfarin (*; were incubated at 37 'C. After the indicated time they were diluted with 10 ml of a solution containing 10 mll NaHCO3, pH 7.8 and adsorbed onto BaSOo (20 mg). The BaSOu was washed three times with the bicarbonate solution and each time removed by centrifugation. Finally, the BaSOo was suspended in Aquasol-2 (NEN) and counted as such.
into factor II is observed. It might be that one of the reaction components has run out. Addition of more synthetase, however, does not lead to more prothrombin synthesis. Therefore, we added purified factor II to reaction mixtures before or during the incubation. In this way it proved that the reaction could be stopped immediately at any stage of prothrombin synthesis by adding 0.1 U/ml of purified factor II. So it is very probable that the synthesis of factor II in normal reaction mixtures stops, because a certain irmount of factor II is synthesized. The reaction can only be started again by adding more decarboxyfactor II. Also when we studied the incorporation of laCO, we observed this inhibition of the reaction by factor II ( fig. 3B ).
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Without doubts more details of the reaction mechanism of the conversion of decarboxyfactor II into factor II remain to be unraveled. For this kind of research the bovine synthetase enzyme system provides good possibilities, where other systems (rat) fail. This is because only in the bovine system it is possible to separate the enzyme (synthetase) from its substrate (decarboxyfactor II). The high degree of purification of bovine synthetase (about 10,000-fold) is a second advantage of our system. Obviously the final purification of the enzyme is required before the reaction mechanism can be studied in more detail.
